Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.
about
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathwayPICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway.Alterations of the WNT7A gene in clear cell renal cell carcinomasChallenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data.PICT1 expression is a poor prognostic factor in non-small cell lung cancer.A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models.NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Expression and prognostic significance of wnt7a in human endometrial carcinomaA new PICTure of nucleolar stress.Scission of the p53-MDM2 Loop by Ribosomal Proteins.IFITMs restrict the replication of multiple pathogenic virusesp53 -Dependent and -Independent Nucleolar Stress Responses.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.The protein interacting with carboxyl terminus-1 codon 389 polymorphism impairs protein interacting with carboxyl terminus-1 function and is a risk factor for uterine cervical cancer.Regulatory network involving miRNAs and genes in serous ovarian carcinoma.Multifunctional viral protein γ34.5 manipulates nucleolar protein NOP53 for optimal viral replication of HSV-1.GRWD1, a new player among oncogenesis-related ribosomal/nucleolar proteins.
P2860
Q29976922-E7017058-C4F4-41F0-9DDD-813B30152552Q30032659-53233BCA-9BA3-487F-B732-C06F50340862Q30090233-6CF7C14C-E45C-40D7-8C88-F74E06EC4901Q30090238-F2A9E85C-3468-4862-B446-DDF6A01F99EDQ34442670-E61FF4EC-82D3-4804-910B-AC0553314B7DQ34555631-9CBAC662-8A56-4616-9EEC-533BAF6614E2Q34781290-AC5AD7AD-C4DF-4C26-A4BF-24DFBCDD3E34Q36176058-B750B9BF-5F1A-4451-9463-0AC1DA93514EQ36396570-3AFCE4AC-8958-4748-88B9-C99AD2F369F4Q36470501-2BEE0DCB-B479-4CBA-B4FE-FF4EC5AD6B38Q37982800-E5035487-3613-426B-BDD1-93C136C0F85AQ38059701-E2D977E9-4407-4DC5-A660-3E51D32663B8Q38146443-DBCA9E13-58EC-4E3D-835C-F73EE7A597A8Q38202877-6A091D33-7E5E-4979-9235-0456140D8116Q38432883-23496472-640E-4100-BA2F-17C0ED6EF5D7Q38725292-9BA855CC-E87C-47A4-8706-9D0D219D3D30Q45874094-5B2E3F9B-8179-4851-9B97-F3A954D7302EQ47549132-03689F56-0EBA-4AC8-BAFD-A465531B4BFEQ48102567-FC2309E1-B9DE-4B34-A290-D839C87E773F
P2860
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expression profiling identifie ...... tion of serous ovarian cancer.
@ast
Expression profiling identifie ...... tion of serous ovarian cancer.
@en
Expression profiling identifie ...... tion of serous ovarian cancer.
@nl
type
label
Expression profiling identifie ...... tion of serous ovarian cancer.
@ast
Expression profiling identifie ...... tion of serous ovarian cancer.
@en
Expression profiling identifie ...... tion of serous ovarian cancer.
@nl
prefLabel
Expression profiling identifie ...... tion of serous ovarian cancer.
@ast
Expression profiling identifie ...... tion of serous ovarian cancer.
@en
Expression profiling identifie ...... tion of serous ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Expression profiling identifie ...... tion of serous ovarian cancer.
@en
P2093
Adam C Martyn
Adèle C Green
David J Papadimos
Melissa A Merritt
Tanya R Newton
P2860
P2888
P356
10.1186/1471-2407-9-378
P407
P577
2009-10-23T00:00:00Z
P5875
P6179
1045708912